Cargando…
Localized Controlled Release of Kynurenic Acid Encapsulated in Synthetic Polymer Reduces Implant—Induced Dermal Fibrosis
Excessive fibrosis following surgical procedures is a challenging condition with serious consequences and no effective preventive or therapeutic option. Our group has previously shown the anti-fibrotic effect of kynurenic acid (KynA) in vitro and as topical cream formulations or nanofiber dressings...
Autores principales: | Nabai, Layla, Ghahary, Aziz, Jackson, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331703/ https://www.ncbi.nlm.nih.gov/pubmed/35893802 http://dx.doi.org/10.3390/pharmaceutics14081546 |
Ejemplares similares
-
Novel, Blended Polymeric Microspheres for the Controlled Release of Methotrexate: Characterization and In Vivo Antifibrotic Studies
por: Nabai, Layla, et al.
Publicado: (2023) -
Fibroblast cell-based therapy prevents induction of alopecia areata in an
experimental model
por: Jalili, Reza B, et al.
Publicado: (2018) -
Serum kynurenic acid is reduced in affective psychosis
por: Wurfel, B E, et al.
Publicado: (2017) -
Synthetic, Natural, and Semisynthetic Polymer Carriers for Controlled Nitric Oxide Release in Dermal Applications: A Review
por: Gutierrez Cisneros, Carolina, et al.
Publicado: (2021) -
M-CSF-stimulated myeloid cells can convert into epithelial cells to participate in re-epithelialization and hair follicle regeneration during dermal wound healing
por: Li, Yunyuan, et al.
Publicado: (2022)